Autopsy report · NCT01048853
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
Cause of deathSlow enrollment
“\< 75% participation”
Life of this trial
- Registered 3 months before it started.
- Ran for about 15 years 8 months before it stopped.
- 137 participants enrolled.
- Results were posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Cervical Adenocarcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Stage IA2 Cervical Cancer AJCC v6 and v7; Stage IB1 Cervical Cancer AJCC v6 and v7
- Interventions
- Lymph Node Mapping; Quality-of-Life Assessment; Salpingo-Oophorectomy; Sentinel Lymph Node Biopsy; Therapeutic Conventional Surgery
- Participants
- 137
- Sites
- 20
- Countries
- Argentina, Australia, Brazil, Colombia, Mexico, Peru, Thailand, United States
Trials that died the same way
- ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome
“\<75% participants” - Vapocoolant Analgesia for Breast Lymphoscintigraphy
“\<75% accrued participants” - Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery
“low participation rate” - Physiotherapy and Therapeutic Education After Total Knee Arthroplasty.
“low participation” - Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy
“Lack of participations (8 of 25)”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.